Elizabeth Rubalcaba
- Co-authors
- Raphael P. ViscidiFrank T. LindgrenLoren A. ZechErnst J. SchaeferH B BrewerRoger AamodtThomas J. BronzertBarbara Clayman
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers)Glycosylation and Glycoproteins Research (1 paper)Cholesterol and Lipid Metabolism (1 paper)
- Partner nations
- United States
In The Last Decade
Elizabeth Rubalcaba
8 papers receiving 493 citations
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 164
- Oncology 149
- Surgery 148
- Molecular Biology 134
- Cancer Research 92
Countries citing papers authored by Elizabeth Rubalcaba
This map shows the geographic impact of Elizabeth Rubalcaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Rubalcaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Rubalcaba more than expected).
Fields of papers citing papers by Elizabeth Rubalcaba
This network shows the impact of papers produced by Elizabeth Rubalcaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Rubalcaba. The network helps show where Elizabeth Rubalcaba may publish in the future.
Co-authorship network of co-authors of Elizabeth Rubalcaba
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Rubalcaba. A scholar is included among the top collaborators of Elizabeth Rubalcaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Rubalcaba. Elizabeth Rubalcaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 119 | |
| 3 | 55 | |
| 4 | 19 | |
| 5 | Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line. | 25 |
| 6 | 179 | |
| 7 | 61 | |
| 8 | 35 |
About Elizabeth Rubalcaba
Elizabeth Rubalcaba is a scholar working on Virology, Hepatology and Endocrinology, Diabetes and Metabolism, having authored 8 papers that have together received 517 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Virology (49 citations), Endocrinology, Diabetes and Metabolism (164 citations) and Cancer Research (92 citations). Elizabeth Rubalcaba has collaborated with scholars based in United States. Frequent co-authors include Raphael P. Viscidi, Frank T. Lindgren, Loren A. Zech, Ernst J. Schaefer, H B Brewer, Roger Aamodt, Thomas J. Bronzert, Barbara Clayman, Dana E. Rollison and Richard Daniel. Their work appears in journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.